Michael Farkouh MD
Associate Clinical Professor, Medicine - Cardiology, Icahn School of Medicine at Mount Sinai
Join to View Full Profile
127 S San Vicente BlvdSte 3600Los Angeles, CA 90048
Phone+1 310-423-2726
Fax+1 310-423-6795
Dr. Farkouh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1996 - 1998
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
University of Western OntarioClass of 1988
Certifications & Licensure
CA State Medical License 2025 - 2027
NY State Medical License 2009 - 2026
MN State Medical License 1989 - 1996
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) Start of enrollment: 2004 Apr 01
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials Start of enrollment: 2019 Oct 01
- The Açaí Berry COVID-19 Anti-Inflammation Trial Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- Revascularization Recommendations for Patients with Multivessel Coronary Artery Disease: Reestablished at Last.Marc Ruel, Michael E Farkouh, Michelle Graham, Rosemary F Kelly, Maral Ouzounian
The Canadian Journal of Cardiology. 2025-08-01 - Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.Sylvain A Lother, Wen Teng, Olawale Ayilara, Brett L Houston, Barret Rush
Research and Practice in Thrombosis and Haemostasis. 2025-05-01 - 1 citationsThe Role of GLP-1 Receptor Agonists in Heart Failure: Promise and Unanswered Questions.Michael E Farkouh, Jairo T Nunes
JACC. Heart Failure. 2025-05-01
Journal Articles
- Moving Beyond the StentMichael Farkouh, MD, JACC: Cardiovascular Imaging
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Join now to see all
Press Mentions
BlackDoctor.org: 4 Health Experts Address Clinical Trials Myths and AssumptionsJune 18th, 2025- CTSNet Webinar: Unifying Revascularization Guidelines Across Continents and SpecialtiesJanuary 22nd, 2025
- Cedars-Sinai Taps Renowned Cardiologist as Associate Dean of Clinical TrialsJanuary 19th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
